Ovarian Clear Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Clear Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) [Phase 3]
Phase 3 clinical trial evaluating Olvi-Vec in combination with platinum-doublet chemotherapy and Bevacizumab versus physician's choice of ch…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of CYH33 in patients with recurrent/persistent ovarian clear cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating the safety and efficacy of dostarlimab plus LB-100 targeting PP2A in ovarian clear cell carcinoma, and it is…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with lenvatinib for ovarian clear cell carcinoma; the trial is currently active but no…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial update evaluating liposomal irinotecan in combination with sintilimab and anlotinib for recurrent or persis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
A clinical trial update evaluating the efficacy and safety of sacituzumab govitecan in patients with ovarian clear cell carcinoma after prog…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer [Phase 1]
Nuvectis Pharma's NXP800 is being studied in a Phase 1 trial for advanced solid tumors with expansion into ovarian cancer, and the study is …
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: RC48 in Combination With AK104 and Bevacizumab in OCCC [Phase 2]
Phase 2 clinical trial evaluating RC48 in combination with AK104 and bevacizumab for ovarian cancer, including ovarian clear cell carcinoma,…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma [Phase 3]
A Phase 3 clinical trial investigating QL1706 in combination with bevacizumab for advanced first-line ovarian clear cell carcinoma; the stud…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update for Tulmimetostat DZR123 (CPI-0209) in adults with advanced solid tumors and various lymphomas. The study is in Phase …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating tazemetostat for recurrent ovarian or endometrial cancers; the study is currently not recruiting…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing
Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma [Phase 2]
Completed Phase 2 study of sintilimab plus bevacizumab in recurrent/persistent ovarian clear cell carcinoma.
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
This clinical trial update describes a real-world study evaluating treatments for ovarian clear cell carcinoma. It is currently recruiting a…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating zimberelimab in combination with metformin for recurrent ovarian clear cell carcinoma is underway (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: A Study of ENMD-2076 in Ovarian Clear Cell Cancers [Phase 2]
Phase 2 trial studying ENMD-2076 in ovarian clear cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update for sunitinib in patients with recurrent ovarian clear cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas [Phase 2]
Multicenter Phase II randomized study comparing durvalumab to physician's choice chemotherapy in recurrent ovarian clear cell carcinoma; cur…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has bee…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Temsirolimus, Carboplatin, and Paclitaxel as first-line therapy for newly diagnosed stage III-IV clear cell ovarian…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium [Phase 2]
A Phase 2 trial is comparing nintedanib against chemotherapy in patients with recurrent ovarian clear cell carcinoma or recurrent endometria…